Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Results of a 12-month, randomized, placebo-controlled study

Nancy E Lane, Gary C. Armitage, Peter Loomer, Susan Hsieh, Sharmila Majumdar, H. Y. Wang, Marjorie Jeffcoat, Thelma Munoz

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Background: Bone loss in periodontitis results from inflammatory reactions that stimulate osteoclastic bone resorption. Bisphosphonates inhibit bone resorption and increase bone mass. This study evaluated the effect of bisphosphonate therapy as an adjunct to non-surgical periodontal treatment in patients with moderate to severe chronic periodontitis. Methods: Patients were randomized (2:1) to one of two bisphosphonate therapies or placebo for 1 year. All patients received non-surgical periodontal treatment (scaling, root planing) and periodontal maintenance therapy every 3 months. Clinical assessments at baseline and 6 and 12 months included clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP). Periodontal bone mass was assessed by dental radiographs at baseline and 12 months using fractal analysis and digital subtraction radiography (DSR). Results: Seventy patients were randomized, 43 to the bisphosphonate group and 27 to the placebo group. Bisphosphonate therapy significantly improved CAL, PD, and BOP relative to the placebo group during the 6- to 12-month period (CAL, P=0.0002; PD, P=0.0156; BOP, P=0.0079). There was no difference in the change in periodontal bone mass between the bisphosphonate and placebo groups as measured by fractal analysis and DSR. Conclusion: These data suggest that bisphosphonate treatment improves the clinical outcome of non-surgical periodontal therapy and may be an appropriate adjunctive treatment to preserve periodontal bone mass.

Original languageEnglish (US)
Pages (from-to)1113-1122
Number of pages10
JournalJournal of Periodontology
Volume76
Issue number7
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Diphosphonates
Placebos
Bone and Bones
Radiographic Image Enhancement
Fractals
Therapeutics
Bone Resorption
Hemorrhage
Root Planing
Chronic Periodontitis
Periodontitis
Tooth

Keywords

  • Bisphosphonates/therapeutic use
  • Bone loss/prevention and control
  • Clinical trials, randomized
  • Periodontal diseases/prevention and control
  • Periodontal diseases/therapy
  • Planning
  • Scalling
  • Tooth root

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Bisphosphonate therapy improves the outcome of conventional periodontal treatment : Results of a 12-month, randomized, placebo-controlled study. / Lane, Nancy E; Armitage, Gary C.; Loomer, Peter; Hsieh, Susan; Majumdar, Sharmila; Wang, H. Y.; Jeffcoat, Marjorie; Munoz, Thelma.

In: Journal of Periodontology, Vol. 76, No. 7, 07.2005, p. 1113-1122.

Research output: Contribution to journalArticle

Lane, Nancy E ; Armitage, Gary C. ; Loomer, Peter ; Hsieh, Susan ; Majumdar, Sharmila ; Wang, H. Y. ; Jeffcoat, Marjorie ; Munoz, Thelma. / Bisphosphonate therapy improves the outcome of conventional periodontal treatment : Results of a 12-month, randomized, placebo-controlled study. In: Journal of Periodontology. 2005 ; Vol. 76, No. 7. pp. 1113-1122.
@article{40a24b1bfc0b4736b9781623e72c3414,
title = "Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Results of a 12-month, randomized, placebo-controlled study",
abstract = "Background: Bone loss in periodontitis results from inflammatory reactions that stimulate osteoclastic bone resorption. Bisphosphonates inhibit bone resorption and increase bone mass. This study evaluated the effect of bisphosphonate therapy as an adjunct to non-surgical periodontal treatment in patients with moderate to severe chronic periodontitis. Methods: Patients were randomized (2:1) to one of two bisphosphonate therapies or placebo for 1 year. All patients received non-surgical periodontal treatment (scaling, root planing) and periodontal maintenance therapy every 3 months. Clinical assessments at baseline and 6 and 12 months included clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP). Periodontal bone mass was assessed by dental radiographs at baseline and 12 months using fractal analysis and digital subtraction radiography (DSR). Results: Seventy patients were randomized, 43 to the bisphosphonate group and 27 to the placebo group. Bisphosphonate therapy significantly improved CAL, PD, and BOP relative to the placebo group during the 6- to 12-month period (CAL, P=0.0002; PD, P=0.0156; BOP, P=0.0079). There was no difference in the change in periodontal bone mass between the bisphosphonate and placebo groups as measured by fractal analysis and DSR. Conclusion: These data suggest that bisphosphonate treatment improves the clinical outcome of non-surgical periodontal therapy and may be an appropriate adjunctive treatment to preserve periodontal bone mass.",
keywords = "Bisphosphonates/therapeutic use, Bone loss/prevention and control, Clinical trials, randomized, Periodontal diseases/prevention and control, Periodontal diseases/therapy, Planning, Scalling, Tooth root",
author = "Lane, {Nancy E} and Armitage, {Gary C.} and Peter Loomer and Susan Hsieh and Sharmila Majumdar and Wang, {H. Y.} and Marjorie Jeffcoat and Thelma Munoz",
year = "2005",
month = "7",
doi = "10.1902/jop.2005.76.7.1113",
language = "English (US)",
volume = "76",
pages = "1113--1122",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "7",

}

TY - JOUR

T1 - Bisphosphonate therapy improves the outcome of conventional periodontal treatment

T2 - Results of a 12-month, randomized, placebo-controlled study

AU - Lane, Nancy E

AU - Armitage, Gary C.

AU - Loomer, Peter

AU - Hsieh, Susan

AU - Majumdar, Sharmila

AU - Wang, H. Y.

AU - Jeffcoat, Marjorie

AU - Munoz, Thelma

PY - 2005/7

Y1 - 2005/7

N2 - Background: Bone loss in periodontitis results from inflammatory reactions that stimulate osteoclastic bone resorption. Bisphosphonates inhibit bone resorption and increase bone mass. This study evaluated the effect of bisphosphonate therapy as an adjunct to non-surgical periodontal treatment in patients with moderate to severe chronic periodontitis. Methods: Patients were randomized (2:1) to one of two bisphosphonate therapies or placebo for 1 year. All patients received non-surgical periodontal treatment (scaling, root planing) and periodontal maintenance therapy every 3 months. Clinical assessments at baseline and 6 and 12 months included clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP). Periodontal bone mass was assessed by dental radiographs at baseline and 12 months using fractal analysis and digital subtraction radiography (DSR). Results: Seventy patients were randomized, 43 to the bisphosphonate group and 27 to the placebo group. Bisphosphonate therapy significantly improved CAL, PD, and BOP relative to the placebo group during the 6- to 12-month period (CAL, P=0.0002; PD, P=0.0156; BOP, P=0.0079). There was no difference in the change in periodontal bone mass between the bisphosphonate and placebo groups as measured by fractal analysis and DSR. Conclusion: These data suggest that bisphosphonate treatment improves the clinical outcome of non-surgical periodontal therapy and may be an appropriate adjunctive treatment to preserve periodontal bone mass.

AB - Background: Bone loss in periodontitis results from inflammatory reactions that stimulate osteoclastic bone resorption. Bisphosphonates inhibit bone resorption and increase bone mass. This study evaluated the effect of bisphosphonate therapy as an adjunct to non-surgical periodontal treatment in patients with moderate to severe chronic periodontitis. Methods: Patients were randomized (2:1) to one of two bisphosphonate therapies or placebo for 1 year. All patients received non-surgical periodontal treatment (scaling, root planing) and periodontal maintenance therapy every 3 months. Clinical assessments at baseline and 6 and 12 months included clinical attachment level (CAL), probing depth (PD), and bleeding on probing (BOP). Periodontal bone mass was assessed by dental radiographs at baseline and 12 months using fractal analysis and digital subtraction radiography (DSR). Results: Seventy patients were randomized, 43 to the bisphosphonate group and 27 to the placebo group. Bisphosphonate therapy significantly improved CAL, PD, and BOP relative to the placebo group during the 6- to 12-month period (CAL, P=0.0002; PD, P=0.0156; BOP, P=0.0079). There was no difference in the change in periodontal bone mass between the bisphosphonate and placebo groups as measured by fractal analysis and DSR. Conclusion: These data suggest that bisphosphonate treatment improves the clinical outcome of non-surgical periodontal therapy and may be an appropriate adjunctive treatment to preserve periodontal bone mass.

KW - Bisphosphonates/therapeutic use

KW - Bone loss/prevention and control

KW - Clinical trials, randomized

KW - Periodontal diseases/prevention and control

KW - Periodontal diseases/therapy

KW - Planning

KW - Scalling

KW - Tooth root

UR - http://www.scopus.com/inward/record.url?scp=23044488738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044488738&partnerID=8YFLogxK

U2 - 10.1902/jop.2005.76.7.1113

DO - 10.1902/jop.2005.76.7.1113

M3 - Article

C2 - 16018754

AN - SCOPUS:23044488738

VL - 76

SP - 1113

EP - 1122

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 7

ER -